BK vs RNXT · P/E 17, rev $20.08B vs rev $266.0K
The Bank of New York Mellon Corporation (BK) versus RenovoRx Inc (RNXT) — a side-by-side from cached financials, not a winner call.
The Bank of New York Mellon Corporation (BK) is a banks - diversified company listed on US.
RenovoRx Inc (RNXT) is a biotechnology company listed on US.
Latest reported BK revenue for 2025-12-31 was $20.08B. Net income was $5.55B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. BK currently screens at market cap $94.14B and trailing P/E 17.0.
Latest reported RNXT revenue for 2025-09-30 was $266.0K. Net income was -$2.9M. Revenue was down 37.0% from 2025-06-30 to 2025-09-30. RNXT currently screens at market cap $47.0M.
BK currently screens at market cap $94.14B and trailing P/E 17.0. RNXT currently screens at market cap $47.0M.
Not investment advice. Open the BK and RNXT stock pages for the full models.
Not investment advice.